Time to fix the business model for new antibiotics

Trana Discovery fully supports the appeal by Michelle McMurry-Heath, MD, PhD and Pres./CEO of Biotechnology Innovation Organization [BIO] to create a new business model for drug development with antibiotics.  With the increasing threat of multi-drug resistant infections becoming untreatable, a new approach is necessary.

Among other items, she encourages everyone to support the 2 bills in Congress that may ameliorate the problem (DISARM Act & the PASTEUR Act).  Currently, multi-drug resistant microorganisms kill 700,000 worldwide every year.  It is estimated that possibly 10 million people will die from infections caused by these organisms by 2050.

For more information, read here